Swiss agree to extradite Chinese researcher in US corporate espionage case
The case has exacerbated global fears that China is using networks of highly trained nationals abroad to gain trade secrets,
swissinfo.ch
This content was published on
2 minutes
The Swiss Federal Office of Justice (FOJ)External link has approved the extradition of a Chinese researcher to the United States. Gongda Xue is charged with using trade secrets stolen from a factory of the British pharmaceutical group GlaxoSmithKline (GSK).
The decision was taken on July 12, from which date the researcher has 30 days to appeal to the Federal Criminal Court, a spokeswoman for the FOJ told the French news agency, AFP, on Tuesday.
Gongda Xue is the brother of Yu Xue, a Chinese-American biochemist who pleaded guilty last year at a US District Court in Pennsylvania to stealing trade secrets on GSK’s work in the biopharmaceutical sector, including the treatment of cancer and other serious diseases.
A total of five people were charged in the case, three of whom formed a company in China called Renopharma to sell the stolen trade secrets.
Yu Xue, who worked for GSK from 2006 to 2016, had been presented by the American courts as one of the “leading protein biochemists in the world”.
According to a spokeswoman for the Friedrich Miescher Institute for Biomedical Research, Gongda Xue worked there “as a postdoctoral fellow from 2008 to 2014”.
The US Department of Justice last year called the case an “economic war”, claiming that Renopharma, based in Nanjing, China, is “financed by the Chinese government”.
Popular Stories
More
Workplace Switzerland
Trump tariff shock: how Switzerland is positioning itself
Is your place of origin, your Heimatort, important to you?
Every Swiss citizen has a Heimatort, a place of origin, but many have never visited theirs. What’s your relationship with your Heimatort? What does it mean to you?
What factors should be taken into account when inheriting Swiss citizenship abroad?
Should there be a limit to the passing on of Swiss citizenship? Or is the current practice too strict and it should still be possible to register after the age of 25?
Major road disruptions continue after heavy snowfall in parts of Switzerland
This content was published on
The snowfall has ended in the southern Swiss canton of Valais, the cantonal emergency services said on Friday. Several roads, however, remain closed.
Swiss businessman gets prison term for asbestos deaths
This content was published on
Stephan Schmidheiny has been sentenced to 9 years and 6 months in prison by the Turin Court of Appeal in a case against the former Eternit executive over deaths linked to asbestos exposure in Italy.
This content was published on
Swiss imports and exports reached new heights in the first quarter, driven by the chemicals and pharmaceuticals sectors. Shipments to the US rose sharply.
Italian in Switzerland accused of being Calabrian mafia henchman
This content was published on
The Office of the Attorney General of Switzerland has charged an Italian resident of the Anello-Fruci 'Ndrangheta clan in the canton of Aargau.
Swiss CFOs have a pessimistic outlook due to trade wars
This content was published on
In the wake of the trade wars launched by US President Donald Trump, Swiss companies are assessing the future much more pessimistically.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss firms in record number of mergers and acquisitions
This content was published on
The number of merger and acquisition deals involving Swiss companies hit a record high in 2018, according to a report by consultancy firm KPMG.
This content was published on
In recent days, Johnson & Johnson has been urged to review its sprawling portfolio that ranges from baby oil to cancer drugs, and there were questions for Novartis over the future of its struggling eyecare business. This week, Pfizer will update shareholders on plans for a potential break-up, while GlaxoSmithKline is likely to be pressed…
Chinese researcher in ‘economic warfare’ case loses appeal
This content was published on
A Chinese scientist, accused by the US of helping to steal trade secrets, must remain in Swiss custody due to flight risk, says a federal court.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.